Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints
Lupus nephritis (LN) is a common manifestation of systemic lupus erythematosus (SLE) and a major driver of morbidity and mortality. Proliferative forms of LN are typically managed with immunosuppressive therapy, with the aim of attenuating renal inflammation and preserving kidney function.1Almaani S...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | 英语 |
| 出版: |
2020
|
| 在線閱讀: | https://doi.org/10.1016/j.ekir.2020.05.011 http://www.kireports.org/article/S2468024920312729/pdf |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|